Cargando…

Efficacy of the endotoxin absorption method (PMX) in patients with septic shock associated with intraperitoneal infections

Detalles Bibliográficos
Autores principales:	Ikeda, T, Ikeda, K, Onizuka, T, Suzuki, H, Suzuki, K, Maruya, H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2000
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332966/ http://dx.doi.org/10.1186/cc762

Ejemplares similares

Effect of PMX-DHP according to differences in infection site
por: Ikeda, T, et al.
Publicado: (2001)

Is it true that PMX-DHP can improve lung oxygenation?
por: Ikeda, T, et al.
Publicado: (2003)

Clinical evaluation of endotoxin hemoadsorption therapy (PMX-DHP) for hypercytokinemia caused by septic multiple organ failure
por: Ikeda, T, et al.
Publicado: (2004)

The role of plasminogen activator inhibitor 1 measurement with endotoxin adsorption therapy (PMX-DHP) for postoperative septic shock patients
por: Ikeda, T, et al.
Publicado: (2007)

Changes in plasminogen activator inhibitor-1 (PAI-1) in patients with severe sepsis or septic shock
por: Ikeda, T, et al.
Publicado: (2002)

Effects of endotoxin elimination therapy using polymyxin B immobilized fiber in patients with septic shock after surgical operation
por: Ikeda, T, et al.
Publicado: (1997)

Pan-peritonitis due to intestinal perforation, and efficacy of direct hemoperfusion with polymyxin B immobilized fiber (PMX-20R)
por: Ikeda, T
Publicado: (1999)

Therapeutic Rationale for Endotoxin Removal with Polymyxin B Immobilized Fiber Column (PMX) for Septic Shock
por: Shoji, Hisataka, et al.
Publicado: (2021)

Induction of endotoxin (ET) tolerance by atoxic endotoxin - a new prophylactic concept to the septic syndrome
por: Staubach, K, et al.
Publicado: (1997)

Does transforming growth factor-β inhibit nitric oxide synthesis and prevent septic shock?
por: Endo , S, et al.
Publicado: (1999)

Changes in procalcitonin in septic shock patients treated with endotoxin adsorption therapy
por: Ikeda, T, et al.
Publicado: (2005)

Changes in the C-type Natriuretic peptide (CNP) and NO derivatives in the plasma and CSF of the patients with subarachnoid hemorrhage (SAH)
por: Ikeda, K, et al.
Publicado: (2000)

Changes in C-type natriuretic peptide (CNP) levels in the plasma and cerebrospinal fluid of the patients with subarachnoid hemorrhage
por: Ikeda, K, et al.
Publicado: (1999)

Changes in complement cascade during continuous hemodiafiltration (CHDF) in patients with sepsis
por: Ikeda, K, et al.
Publicado: (2002)

Observational study for direct hemoperfusion therapy with polymyxin-B immobilized fibers (PMX-DHP) in patients with septic shock in Japan: PMX-DHP study group
por: Kase, Y, et al.
Publicado: (2009)

Effect of hypertonic dextran on intestinal mucosal perfusion during porcine endotoxin shock
por: Oi, Y, et al.
Publicado: (1999)

Cellular mechanisms of acute septic cardiomyopathy: cardiodepressive profiles of endotoxin, tumor necrosis factor α and interleukin-1 in the cardiomyocyte
por: Müller-Werdan, U, et al.
Publicado: (1997)

Preload assessment in septic shock
por: Donati, A, et al.
Publicado: (2000)

Hypocalcemia in children with septic shock
por: Buysse, CMP, et al.
Publicado: (2001)

Determinants of natriuretic peptides in early septic shock
por: Witthaut, R, et al.
Publicado: (1998)

Endotoxin hemadsorption in septic shock
por: Sunavala, Jamshed D., et al.
Publicado: (2014)

The role of endotoxin in septic shock
por: Kellum, John A., et al.
Publicado: (2023)

Cardiopulmonary dysfunction during porcine endotoxin shock is effectively counteracted by the endothelin receptor antagonist bosentan
por: Waneek, M, et al.
Publicado: (1997)

Bosentan restores gut oxygen delivery and reverses intestinal mucosal acidosis in porcine endotoxin shock
por: Oldner, A, et al.
Publicado: (1997)

Correlation between changes in mediators and number of dysfunctional organs in sepsis-associated multiple organ dysfunction syndrome (MODS)
por: Taniuchi, H, et al.
Publicado: (2003)

Myocardial cell injury in septic shock
por: Rodrigues, MG, et al.
Publicado: (2003)

Effect of continuous hemodiafiltration (CHDF) on vascular endothelial cell function in sepsis patients
por: Ikeda, K, et al.
Publicado: (2003)

Endotoxin-neutralising effect and anti-inflammatory properites of tobramycin and ceftazidime in porcine endotoxic shock
por: Goscinski, G, et al.
Publicado: (2003)

Terlipressin in the treatment of catecholamine resistant septic shock
por: Auzinger, GM, et al.
Publicado: (2002)

Septic shock etiology in kidney transplant recipients
por: De Marco, FVC, et al.
Publicado: (2002)

Continuous hemodiafiltration with bicarbonate- and lactate-buffered replacement fluids in septic shock
por: Lewejohann, J-C, et al.
Publicado: (1999)

Endotoxin removal by hemoperfusion in septic shock
por: Adamik, B, et al.
Publicado: (2011)

Diagnostic determinants for capillary leakage syndrome (CLS) in septic shock patients
por: Marx, G, et al.
Publicado: (1999)

Decreased beating rate variability of cultured cardiomyocytes by endotoxin
por: Schmidt, H, et al.
Publicado: (1999)

Early use of endotoxin absorption by oXiris in abdominal septic shock: A case report
por: Wei, Tiantian, et al.
Publicado: (2020)

Plasmafiltration in septic shock: a review of 15 cases
por: Campos, P, et al.
Publicado: (2003)

Severity stratification of septic shock according to noradrenaline requirement
por: Hernández, G, et al.
Publicado: (2001)

Severity stratification of septic shock according to noradrenaline requirement
por: Hernández, G, et al.
Publicado: (2001)

Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis and septic shock
por: Brunkhorst, FM, et al.
Publicado: (1999)

Effect of dopexamine on CO(2) -gradients and splanchnic energy balance in septic shock
por: Kiefer, P, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_lnjl64uus37ldll1e7eo04io5a